Barkby Group Plc. has completed a successful reverse takeover, placing and subscription
The management team of Barkby Group Plc. has completed a reverse takeover of Tarncourt Ambit Properties Limited, Tarncourt Ambit Limited and Workshop Trading Holdings Limited.
Barkby Group is built on a diverse portfolio of businesses within evolving markets. It comprises three separate divisions: life sciences, real estate and consumer and hospitality. Life sciences includes Cambridge Sleep Sciences, which has rights to the exclusive design and production of the SleepHub™ device to improve and facilitate natural sleep, and Vivoplex, a digital health company aiming to transform fertility treatments with precision medicine. The group’s commercial property development specializes in developing contract-backed sites in the southeast of England. The company has a proven profitable track record of sourcing and developing commercial property projects. The consumer and hospitality portfolio is comprised of three separate growth businesses: Workshop Coffee, Barkby Pubs and Centurian Automotive.
During this process, Oaklins Cavendish’s sister firm finnCap, based in the UK, initiated and advised on many aspects, including, among others, securing pre-commitments from cornerstone investors, deal structuring, and the reverse pricing and sizing.
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn moreElectro Optic Systems has acquired the UK interceptor business of MARSS
Electro Optic Systems Holdings Limited (ASX: EOS) has acquired the UK-based interceptor unmanned aerial system business of MARSS Group for US$6.4 million (€5.5 million). The interceptor is a reusable electric drone effector guided by imaging sensors and AI, which EOS will integrate into its counter-drone portfolio for defense and critical infrastructure customers. EOS plans further investment to complete development.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn more